-
Winter School
TIMELINES oninFerring became the main sponsor of the ESPE (European Society for Paediatric Endocrinology) Winter School for young paediatric endocrinologists from…
0 -
Launch of MENOGON
TIMELINES oninIn June of this year Ferring launched its first product in the area of infertility, MENOGON® (menotropin) for the treatment…
-
New activities in Prague
TIMELINES oninFerring BV entered into a joint-venture with Léciva a.s., the largest pharmaceutical company in the Czech Republic at that time.
-
New worldwide subsidiaries
TIMELINES oninDuring the 1990s, Ferring accelerated the opening of new subsidiaries in Eastern and Western Europe, South America, Asia, South Africa…
-
Frederik Paulsen Junior becomes Chairman
TIMELINES oninThe founder’s youngest son, Frederik Paulsen, became Chairman of the Ferring Group. At the same time Ferring established Ferring B.V.…
-
Launch of PENTASA
TIMELINES oninFerring launched PENTASA® (mesalazine) for the treatment of inflammatory bowel diseases. This product enabled the company to strengthen its position…
-
Launch of MINIRIN tablet
TIMELINES oninThe MINIRIN® tablet was the first peptide-based pharmaceutical to be successfully formulated for administration in tablet form.
-
Kiel Ferring Foundation
TIMELINES oninDr. Frederik Paulsen was one of the initiators of the Kiel Ferring Foundation, which, since its formation has awarded 20,000…
-
Continuous Expansion
TIMELINES oninFerring began forming global subsidiaries in Europe, North America and Southeast Asia.
-
Launch of GLYPRESSIN
TIMELINES oninFirst registration and launch of GLYPRESSIN® (terlipressin), an analogue of vasopressin, which is used for the treatment of bleeding oesophageal…
TIMELINES
TIMELINES